KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
+3.92%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$57M
AUM Growth
+$57M
(-0.06%)
Cap. Flow
+$2.76M
Cap. Flow
% of AUM
4.85%
Top 10 Holdings %
Top 10 Hldgs %
93.01%
Holding
19
New
1
Increased
3
Reduced
6
Closed
2
Top Buys
| 1 |
Abeona Therapeutics
ABEO
|
$4.85M |
| 2 |
Anavex Life Sciences
AVXL
|
$2.87M |
| 3 |
Qualigen Therapeutics
QLGN
|
$1.15M |
| 4 |
Arcturus Therapeutics
ARCT
|
$189K |
Top Sells
| 1 |
CEMP
Cempra, Inc.
CEMP
|
$4.32M |
| 2 |
Theriva Biologics
TOVX
|
$1.3M |
| 3 |
ADXS
Advaxis, Inc.
ADXS
|
$358K |
| 4 |
Champions Oncology
CSBR
|
$184K |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
$91.6K |
Sector Composition
| 1 | Healthcare | 99.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Corbus Pharmaceuticals
CRBP
$115M
| $21.7M | 38.01% | 2,563,925 | – | – |
|
|
2
Abeona Therapeutics
ABEO
$350M
| $11.4M | 20.08% | 2,359,767 +1,000,000 | +74% | +$4.85M |
|
|
NTBL
3
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $4.17M | 7.32% | 860,605 | – | – |
|
|
4
Anavex Life Sciences
AVXL
$828M
| $2.87M | 5.03% | +724,205 | New | +$2.87M |
|
|
5
Qualigen Therapeutics
QLGN
$3.03M
| $2.58M | 4.53% | 952,434 +425,531 | +81% | +$1.15M |
|
|
6
Arcturus Therapeutics
ARCT
$462M
| $2.53M | 4.44% | 1,205,498 +90,183 | +8% | +$189K |
|
|
AMPE
7
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.49M | 4.37% | 2,738,322 | – | – |
|
8
VolitionRX
VNRX
$74.2M
| $2.09M | 3.67% | 461,538 | – | – |
|
|
ADXS
9
DELISTED
Advaxis, Inc.
ADXS
| $1.61M | 2.83% | 225,000 -50,000 | -18% | -$358K |
|
|
10
Theriva Biologics
TOVX
$3.94M
| $1.55M | 2.72% | 2,034,949 -1,699,200 | -46% | -$1.3M |
|
|
KERX
11
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.17M | 2.06% | 200,000 | – | – |
|
|
LUMO
12
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $962K | 1.69% | 93,533 -8,904 | -9% | -$91.6K |
|
13
Aldeyra Therapeutics
ALDX
$351M
| $727K | 1.28% | 135,800 | – | – |
|
|
ADXSW
14
DELISTED
Advaxis, Inc. Warrants
ADXSW
| $446K | 0.78% | 112,500 | – | – |
|
|
NBSE
15
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $306K | 0.54% | 204,137 -863 | -0.4% | -$1.29K |
|
16
Enlivex Therapeutics
ENLV
$25M
| $214K | 0.38% | 206,054 -44,916 | -18% | -$46.6K |
|
17
Lisata Therapeutics
LSTA
$19.9M
| $157K | 0.28% | 55,579 -202 | -0.4% | -$571 |
|
|
18
Champions Oncology
CSBR
$93.8M
| – | – | -111,111 | Closed | -$184K |
|
|
CEMP
19
DELISTED
Cempra, Inc.
CEMP
| – | – | -180,800 | Closed | -$4.32M |
|